MSF drags govt to Delhi HC over Pfizer's pneumonia vaccine patent
The Indian patent office granted Pfizer a patent for its vaccine PCV13 (13-valent pneumococcal conjugate vaccine), sold here under the brand ‘Prevenar13’ for over 10 years.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | India Health | Meningitis Vaccine | Pfizer | Pneomococcal Vaccine | Pneumonia | Vaccines